Brent Coffey

1.1k total citations
11 papers, 70 citations indexed

About

Brent Coffey is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Brent Coffey has authored 11 papers receiving a total of 70 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Brent Coffey's work include Neuroblastoma Research and Treatments (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). Brent Coffey is often cited by papers focused on Neuroblastoma Research and Treatments (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). Brent Coffey collaborates with scholars based in United States. Brent Coffey's co-authors include D. Williams Parsons, Margaret Mooney, Lauren Saguilig, Nita L. Seibel, Jin Piao, David R. Patton, James V. Tricoli, P. Mickey Williams, Stacey L. Berg and Katherine A. Janeway and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Brent Coffey

10 papers receiving 70 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brent Coffey United States 5 27 25 25 18 15 11 70
Л. Г. Фечина Russia 5 19 0.7× 28 1.1× 27 1.1× 20 1.1× 6 0.4× 40 109
Claire Briandet France 5 9 0.3× 10 0.4× 14 0.6× 12 0.7× 27 1.8× 8 59
Elen Oliveira Brazil 4 10 0.4× 22 0.9× 35 1.4× 24 1.3× 4 0.3× 5 100
BK Smruti India 6 14 0.5× 18 0.7× 25 1.0× 6 0.3× 7 0.5× 11 74
Anne Sophie Carret Canada 4 7 0.3× 10 0.4× 16 0.6× 13 0.7× 6 0.4× 6 73
Odile Minckes France 4 6 0.2× 28 1.1× 14 0.6× 15 0.8× 15 1.0× 12 74
Will Donnellan United States 4 8 0.3× 11 0.4× 37 1.5× 16 0.9× 3 0.2× 6 73
Julia Herzig Germany 4 13 0.5× 7 0.3× 16 0.6× 23 1.3× 3 0.2× 6 73
Wallace Bourgeois United States 5 16 0.6× 8 0.3× 24 1.0× 65 3.6× 7 0.5× 15 137
Jonas Waizenegger Germany 3 9 0.3× 5 0.2× 15 0.6× 23 1.3× 4 0.3× 4 74

Countries citing papers authored by Brent Coffey

Since Specialization
Citations

This map shows the geographic impact of Brent Coffey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brent Coffey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brent Coffey more than expected).

Fields of papers citing papers by Brent Coffey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brent Coffey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brent Coffey. The network helps show where Brent Coffey may publish in the future.

Co-authorship network of co-authors of Brent Coffey

This figure shows the co-authorship network connecting the top 25 collaborators of Brent Coffey. A scholar is included among the top collaborators of Brent Coffey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brent Coffey. Brent Coffey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Gouda, Mohamed A., Filip Jankú, Ying Yuan, et al.. (2025). Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131). Clinical Cancer Research. 31(20). 4299–4310. 1 indexed citations
2.
3.
Lee, Alice A., Alexander J. Chou, P. Mickey Williams, et al.. (2023). Erdafitinb in patients with FGFR-altered tumors: Results from the NCI-COG Pediatric MATCH trial arm B (APEC1621B).. Journal of Clinical Oncology. 41(16_suppl). 10007–10007. 11 indexed citations
4.
Macy, Margaret E., Rajen Mody, Joel M. Reid, et al.. (2023). Palbociclib in solid tumor patients with genomic alterations in the cyclin D-CDK4/6-INK4a-Rb pathway: Results from NCI-COG pediatric MATCH trial Arm I (APEC1621I).. Journal of Clinical Oncology. 41(16_suppl). 10006–10006. 4 indexed citations
5.
Freedman, Neal D., Liliana Brown, Lori M. Newman, et al.. (2022). COVID-19 SeroHub, an online repository of SARS-CoV-2 seroprevalence studies in the United States. Scientific Data. 9(1). 727–727. 4 indexed citations
6.
Vo, Kieuhoa T., Amit J. Sabnis, Sinchita Roy‐Chowdhuri, et al.. (2022). Ulixertinib in patients with tumors with MAPK pathway alterations: Results from NCI-COG Pediatric MATCH trial Arm J (APEC1621J).. Journal of Clinical Oncology. 40(16_suppl). 3009–3009. 7 indexed citations
7.
Chi, Susan, P. Mickey Williams, Sinchita Roy‐Chowdhuri, et al.. (2022). Tazemetostat in patients with tumors with alterations in EZH2 or the SWI/SNF complex: Results from NCI-COG Pediatric MATCH trial Arm C (APEC1621C).. Journal of Clinical Oncology. 40(16_suppl). 10009–10009. 11 indexed citations
8.
Allen, Carl E., Olive S. Eckstein, P. Mickey Williams, et al.. (2021). Selumetinib in patients with tumors with MAPK pathway alterations: Results from Arm E of the NCI-COG pediatric MATCH trial.. Journal of Clinical Oncology. 39(15_suppl). 10008–10008.
9.
Parsons, D. Williams, Katherine A. Janeway, David R. Patton, et al.. (2021). Factors impacting enrollment on NCI-COG Pediatric MATCH trial treatment protocols.. Journal of Clinical Oncology. 39(15_suppl). 10007–10007. 1 indexed citations
10.
Parsons, D. Williams, Katherine A. Janeway, David R. Patton, et al.. (2019). Identification of targetable molecular alterations in the NCI-COG Pediatric MATCH trial.. Journal of Clinical Oncology. 37(15_suppl). 10011–10011. 20 indexed citations
11.
Conley, Barbara A., Robert J. Gray, Alice Chen, et al.. (2016). Abstract CT101: NCI-molecular analysis for therapy choice (NCI-MATCH) clinical trial: interim analysis. Cancer Research. 76(14_Supplement). CT101–CT101. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Л. Г. Фечина Breakdown of academic impact, for papers by Claire Briandet Breakdown of academic impact, for papers by Elen Oliveira Breakdown of academic impact, for papers by BK Smruti Breakdown of academic impact, for papers by Anne Sophie Carret Breakdown of academic impact, for papers by Odile Minckes Breakdown of academic impact, for papers by Will Donnellan Breakdown of academic impact, for papers by Julia Herzig Breakdown of academic impact, for papers by Wallace Bourgeois Breakdown of academic impact, for papers by Jonas Waizenegger
Rankless by CCL
2026